CORMORANT ASSET MANAGEMENT, LLC Information

200 CLARENDON STREET, BOSTON, Massachusetts, 02116, (857) 702-0388

Report Date: 03/31/2016

Position Statistics

Total Positions 85
New Positions 4
Increased Positions 18
Decreased Positions 4
Positions with Activity 22
Sold Out Positions 2
Total Mkt Value (in $ millions) 646

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.43%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 40.82%
Services
Technology
Transportation
Utilities

85 Positions as of 03/31/2016

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
BLUEPRINT MEDICINES CORP COM -1,756 Sold Out 0
SHIRE PLC SPONSORED ADR -230,496 Sold Out 0
CELLECTAR BIOSCIENCES INC WT EXP 082019 29 (0) 52,999
PRONAI THERAPEUTICS INC COM 100 New 53,153
REGULUS THERAPEUTICS INC COM 154 New 30,656
CELLECTAR BIOSCIENCES INC COM 172 (0) 52,999
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR 201 New 25,000
APPLIED GENETIC TECHNOL CORP COM 222 New 17,110
THRESHOLD PHARMACEUTICAL INC COM NEW 355 New 1,000,000
PROVECTUS BIOPHARMACEUTICALS I WT EXP 061920 396 New 2,200,000
EPIRUS BIOPHARMACEUTICALS INC COM 412 New 896,600
NEOS THERAPEUTICS INC COM 436 New 50,000
HTG MOLECULAR DIAGNOSTICS INC COM 448 New 201,000
NANOSTRING TECHNOLOGIES INC COM 491 New 40,000
VERACYTE INC COM 683 New 137,990
GENVEC INC COM NEW 686 New 1,176,235
PROVECTUS BIOPHARMACEUTICALS I COM 704 New 2,200,000
AMICUS THERAPEUTICS INC COM 750 New 150,000
ASCENDIS PHARMA A S SPONSORED ADR 795 New 61,500
AQUINOX PHARMACEUTICALS INC COM 924 New 150,000